DE NARDIS, VELIA
 Distribuzione geografica
Continente #
EU - Europa 823
NA - Nord America 542
AS - Asia 331
AF - Africa 7
SA - Sud America 5
Continente sconosciuto - Info sul continente non disponibili 2
Totale 1.710
Nazione #
US - Stati Uniti d'America 538
DE - Germania 251
CN - Cina 121
SG - Singapore 108
FI - Finlandia 107
IT - Italia 86
SE - Svezia 83
IE - Irlanda 77
FR - Francia 76
UA - Ucraina 74
TR - Turchia 71
GB - Regno Unito 49
IN - India 24
RU - Federazione Russa 11
EG - Egitto 7
BR - Brasile 4
CA - Canada 3
HK - Hong Kong 3
NL - Olanda 3
CZ - Repubblica Ceca 2
EU - Europa 2
VN - Vietnam 2
AR - Argentina 1
BG - Bulgaria 1
CH - Svizzera 1
JP - Giappone 1
KR - Corea 1
LT - Lituania 1
MX - Messico 1
NO - Norvegia 1
Totale 1.710
Città #
Munich 209
Chandler 106
Jacksonville 93
Helsinki 81
Dublin 75
Singapore 61
Southend 44
Princeton 36
The Dalles 35
Izmir 31
New York 30
Dearborn 25
Beijing 19
Nanjing 17
Cambridge 15
Chieti 15
Wilmington 15
Los Angeles 13
Ashburn 12
Nanchang 10
Shenyang 10
Jinan 9
Ningbo 8
Pescara 8
Santa Clara 8
Changsha 5
Jiaxing 5
Jyväskylä 5
Kunming 5
Grevenbroich 4
Hebei 4
Lanzhou 4
Stockholm 4
Zhengzhou 4
Cairo 3
Castignano 3
Duncan 3
Hangzhou 3
Hong Kong 3
Notaresco 3
Padova 3
San Vito Chietino 3
Spoltore 3
Altamura 2
Ancona 2
Boardman 2
Boydton 2
Brno 2
Camerino 2
Changchun 2
Dong Ket 2
Falls Church 2
London 2
Montreal 2
Norwalk 2
Orange 2
Palosco 2
Roda 2
Taizhou 2
Tianjin 2
Turku 2
Washington 2
Amsterdam 1
Ann Arbor 1
Atlanta 1
Belo Horizonte 1
Brooklyn 1
Campobasso 1
Changzhou 1
Dong-gu 1
Fairfield 1
Frankfurt am Main 1
Guangzhou 1
Guardiagrele 1
Hefei 1
Isidro Casanova 1
Lanciano 1
Mexico City 1
Minneapolis 1
Moscow 1
Mountain View 1
Nuremberg 1
Oslo 1
Piracicaba 1
Quzhou 1
Raleigh 1
Rio de Janeiro 1
Silvi 1
Simi Valley 1
Sofia 1
São Paulo 1
Terni 1
Tokyo 1
Toronto 1
Vaglia 1
Zhongxin 1
Zhoukou 1
Totale 1.125
Nome #
Rosuvastatin reduces Matrix Metalloproteinase (MMP)-9 and Plasminogen Activator Inhibitor (PAI)-1 expression via a microRNA-dependent pathway 210
MicroRNA profiling in migraine without aura: Pilot study 186
Overexpression of microRNA-145 in atherosclerotic plaques from hypertensive patients 99
ATP-binding cassette transporter A1 (ABCA1) overexpression in hypercholesterolemic plaques: a potential molecular explanation 98
MicroRNA profiling reveals new potential modulators of insulin-resistance and cardiovascular risk in type 2 diabetes 98
Plasma exosome microRNA profiling unravels a new potential modulator of adiponectin pathway in diabetes: effect of glycemic control 95
Effect of Rosuvastatin on ABCA1 and ABCG1 expression in human atherosclerotic plaques: results from the QUASAR study 94
High dose rosuvastatin increases ABCA1 transporter in human atherosclerotic plaques in a cholesterol-independent fashion 89
Overexpression of ABCA1 in human plaques exposed to hypercholesterolemia: the role of microRNA modulation 88
MicroRNA profiling reveals new potential modulators of insulin-resistance in type 2 Diabetes 87
Hypertension is a determinant of ABCA1 expression in atherosclerotic plaques from hypercholesterolemic patients 85
MicroRNA profiling reveals new potetial modulators of insulin resistance and cardiovascular risk in type 2 diabetes 84
Effect of Rosuvastatin on MicroRNAs expression in human atherosclerotic plaques: results from Quasar Study 83
High dose Rosuvastatin modulates MicroRNA-222 expression in advanced human atherosclerotic plaques 73
null 71
Effect of Rosuvastatin on MicroRNAs expression in Human Atherosclerotic Plaques: Results from Quasar Study 69
Plasma microRNA signature associated with retinopathy in patients with type 2 diabetes 69
Effects of Rosuvastatin on the expression of microRNAs and their putative targets in human atherosclerotic plaques: the QUASAR Study 66
Totale 1.744
Categoria #
all - tutte 6.102
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.102


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202034 0 0 0 0 0 0 0 0 0 0 25 9
2020/202188 15 0 18 10 2 16 1 1 11 12 0 2
2021/202286 0 2 0 25 6 3 3 5 9 2 10 21
2022/2023279 20 36 16 18 28 67 16 18 45 3 6 6
2023/2024144 14 3 3 8 4 51 31 0 0 10 0 20
2024/2025520 12 30 39 1 25 61 117 63 110 14 48 0
Totale 1.744